Shijiazhuang Yiling Pharmaceutical Co., Ltd

Yiling

Shijiazhuang Yiling Pharmaceutical Co., Ltd., a high-tech enterprise, has established a five in one operation mode of "theory - scientific research - new drug - production - Marketing", and established a new drug R & D innovation technology system guided by the theoretical innovation of collateral disease of traditional Chinese medicine.

Shijiazhuang Yiling Pharmaceutical Co., Ltd., a national key high-tech enterprise, was founded by Wu Yiling, academician of Chinese Academy of engineering. Under his leadership, Yiling pharmaceutical always adheres to the scientific and technological innovation development strategy of taking science and technology as the guide and market as the leader, establishes a unique five in one operation mode of "theory - scientific research - New Medicine - production - Marketing", and establishes the collateral disease theory innovation of traditional Chinese medicine as the guide New drug R & D innovation technology system. In the development of Yiling pharmaceutical industry, a large number of elites in scientific research, management, production and marketing have been gathered, including returned experts, foreign experts, doctors, masters and all kinds of higher vocational talents. They train doctors and masters for Hebei Medical University, and have been approved as post doctoral research workstation by the Ministry of personnel. Yiling pharmaceutical promotes the industrialization of traditional Chinese medicine with collateral disease theory innovation, uses modern high-tech to research and develop modern Chinese medicine, western medicine and biological medicine, and develops 9 national patent new drugs, covering major diseases such as cardiovascular and cerebrovascular diseases, cold and respiratory diseases, tumors, diabetes and its complications. Through the national GMP certification of traditional Chinese medicine production line, through the European Union certification of chemical preparation production workshop has an annual output value of 5 billion production capacity. Yiling pharmaceutical is a national innovative enterprise and one of the top 50 pharmaceutical enterprises in China. Yiling trademark has become a well-known trademark in China. The former leader of the Ministry of science and technology of the people's Republic of China once praised the five in one development model as "the pioneering work of industrialization of scientific and technological achievements of Chinese medicine". Based on domestic and international standards, Yiling pharmaceutical has established three international standard scientific research and production bases in Shijiazhuang, Beijing Daxing and Miyun, and has passed the GMP certification of EU and New Zealand. Scientific research, production, quality inspection, trade and management talents all have international background, and a production and quality control system in line with international drug standards has been established. Relying on modern high-tech and equipment and perfect drug production quality control system, we can produce high-quality traditional Chinese medicine and Western medicine. Products have been exported to the United Kingdom, the United States, Spain, South Korea, Japan, Russia, New Zealand and many other countries. Located in Beijing bioengineering and pharmaceutical industry base, Beijing Yiling Pharmaceutical Co., Ltd., covering an area of 210 mu, is a state key high-tech enterprise, mainly producing plant medicine, health care products and dietary supplements for the international market. Located in Miyun, Beijing Yiling biological Co., Ltd. is built according to the GMP standards of Europe and America. It mainly produces hormones, tumor drugs and new preparations with independent intellectual property rights for the international market.